New hope for diabetic foot ulcers: cell therapy tested in phase 3 trial
NCT ID NCT04569409
First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 27 times
Summary
This study tested a treatment called ALLO-ASC-DFU for diabetic foot ulcers that are deep but not infected. It included 104 adults with type 1 or type 2 diabetes. The goal was to see if the treatment helps wounds close completely compared to a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC FOOT ULCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center
Seoul, Seoul, 05505, South Korea
-
Borame Medical Center
Seoul, Seoul, 07061, South Korea
-
Bucheon ST. Mary's Hospital
Gyeonggi-do, Bucheon, 14647, South Korea
-
Korea University Guro Hospital
Seoul, Seoul, 08308, South Korea
-
Seoul National University Bundang Hospital
Gyeonggi-do, Seongnam-si, 13620, South Korea
Conditions
Explore the condition pages connected to this study.